| 1 |
30727907 | Polyethylene Glycol Acts as a Mechanistic Stabilizer of L-asparaginase: A Computational Probing. | 2019 |
4 |
| 2 |
30052638 | Thiol-maleimide poly(ethylene glycol) crosslinking of L-asparaginase subunits at recombinant cysteine residues introduced by mutagenesis. | 2018 |
1 |
| 3 |
28660740 | Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation. | 2017 Dec |
1 |
| 4 |
26695272 | Asymmetrical flow field-flow fractionation for the analysis of PEG-asparaginase. | 2016 |
1 |
| 5 |
25854457 | [Safety of polyethylene glycol conjugated L-asparaginase in patients with acute lymphoblastic leukemia and T cell non-Hodgkin lymphoma]. | 2015 Mar |
2 |
| 6 |
24649212 | A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety. | 2013 May |
2 |
| 7 |
22888537 | A PEGylation technology of L-asparaginase with monomethoxy polyethylene glycol-propionaldehyde. | 2012 May-Jun |
1 |
| 8 |
22042277 | Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). | 2011 Dec |
5 |
| 9 |
22312702 | Formulation of PEG-ylated L-asparaginase loaded poly (lactide-co-glycolide) nanoparticles: influence of Pegylation on enzyme loading, activity and in vitro release. | 2011 Dec |
1 |
| 10 |
20007809 | Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. | 2010 Feb 18 |
1 |
| 11 |
17226958 | Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. | 2007 Jan-Feb |
2 |
| 12 |
17551397 | Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group. | 2007 Jun |
2 |
| 13 |
15328169 | Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. | 2004 Aug 15 |
1 |
| 14 |
12695020 | Stabilisation and determination of the biological activity of L-asparaginase in poly(D,L-lactide-co-glycolide) nanospheres. | 2003 Apr 30 |
1 |
| 15 |
12833461 | A Phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma. | 2003 Jul 1 |
5 |
| 16 |
12022502 | Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in vitro study. | 2002 May-Jun |
1 |
| 17 |
11221967 | A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors. | 2001 |
3 |
| 18 |
10961868 | Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. | 2000 Sep 1 |
1 |
| 19 |
10506705 | Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia. | 1999 Oct 1 |
4 |
| 20 |
9161659 | Pegaspargase: an alternative? | 1997 May |
3 |
| 21 |
7850718 | An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. | 1995 Mar 1 |
2 |
| 22 |
1567419 | Chemical modification of L-asparaginase with a comb-shaped copolymer of polyethylene glycol derivative and maleic anhydride. | 1992 Apr 15 |
1 |
| 23 |
2345067 | A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma. | 1990 Feb |
1 |
| 24 |
3210651 | [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia]. | 1988 May-Jun |
1 |
| 25 |
2872037 | Clinical pharmacology of polyethylene glycol-L-asparaginase. | 1986 May-Jun |
2 |
| 26 |
4041512 | Use of the polyethylene glycol adduct of L-asparaginase for the treatment of hyperasparaginemia in a schizophrenic patient. | 1985 Oct |
3 |